Results
24
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
24 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ADOC | €5.57 | -4.3% | -38.5% | €83.8m | €6.30 | PS13.8x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
ALOKW | €11.84 | -1.3% | -39.1% | €97.8m | €20.75 | PE12.9x | E36.0% | n/a | Capital Goods | ||
VU | €150.00 | 5.9% | 22.3% | €2.4b | €194.50 | PS2.9x | E82.3% | 0.2% | Tech | ||
FDE | €27.25 | 0.9% | -36.6% | €143.8m | €60.33 | PE18.3x | E31.9% | n/a | Energy | ||
OSE | €6.76 | -25.9% | 30.0% | €147.1m | €13.50 | PS66x | E5.9% | n/a | Pharmaceuticals & Biotech | ||
ALMUN | €0.41 | -0.2% | -80.3% | €3.6m | €1.30 | PB0.3x | E149.1% | n/a | Tech | ||
ALCUR | €6.34 | 6.0% | 160.9% | €36.5m | €8.48 | PE20.3x | E27.5% | n/a | Capital Goods | ||
ALICA | €9.62 | -3.4% | -29.8% | €77.8m | €15.00 | PE14.2x | E27.3% | 2.1% | Tech | ||
MEDCL | €16.06 | -4.4% | 146.7% | €467.1m | €22.03 | PS39.1x | E93.9% | n/a | Pharmaceuticals & Biotech | ||
ALSMA | €4.07 | -0.2% | 57.8% | €21.2m | €5.80 | PE20.1x | E35.2% | n/a | Healthcare | ||
ALSTI | €18.70 | 5.4% | n/a | €95.1m | €16.50 | PE47.5x | E28.5% | 1.0% | Capital Goods | ||
ALLIX | €8.75 | -4.3% | -11.6% | €57.4m | €13.50 | PS1.7x | E102.1% | n/a | Software | ||
ALECP | €0.55 | -2.1% | -17.0% | €67.4m | n/a | PE74.9x | E86.8% | 0% | Media | ||
ALVGO | €3.09 | -0.3% | -20.2% | €18.8m | €4.40 | PS1.5x | E77.2% | n/a | Software | ||
ALHOP | €22.30 | -1.3% | 39.8% | €64.0m | €30.40 | PE14x | E22.3% | 2.9% | Media | ||
ALCIS | €8.16 | -1.4% | -8.9% | €63.5m | €12.10 | PE19.9x | E56.5% | 2.0% | Commercial Services | ||
LSS | €28.85 | 1.9% | 9.7% | €1.1b | €34.58 | PE34.2x | E29.3% | 1.2% | Software | ||
OVH | €6.17 | 3.6% | -30.9% | €1.2b | €9.35 | PS1.2x | E101.1% | n/a | Software | ||
GUI | €5.04 | -6.0% | -23.9% | €75.8m | €7.85 | PE78.6x | E55.0% | 0% | Tech | ||
S30 | €1.54 | 2.9% | -40.4% | €165.4m | €2.17 | PB1.5x | E100.6% | n/a | Software | ||
CLA | €1.36 | -5.2% | -16.3% | €77.2m | €4.65 | PE-15.4x | E88.7% | n/a | Software | ||
ALPAT | €14.80 | -5.1% | 24.4% | €16.4m | €11.50 | n/a | E92.7% | n/a | Pharmaceuticals & Biotech | ||
ALBLD | €15.25 | -1.3% | -3.5% | €69.3m | €21.43 | PE24.7x | E30.5% | n/a | Media | ||
EXN | €23.55 | 0.4% | 31.4% | €2.1b | €25.33 | PE52.1x | E33.7% | 0% | Software |